CIK 0001645469 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 0 | 0 | ||
| Net income (USD) | -10.5 M | -9.1 M |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-05 | 4 | FORM 4 | 2026-10-01 |
| 2026-10-02 | 4 | FORM 4 | 2026-09-30 |
| 2026-10-02 | 4 | FORM 4 | 2026-09-30 |
| 2026-10-02 | 4 | FORM 4 | 2026-09-30 |
| 2026-10-01 | 144 | 144 | |
| 2026-09-28 | 4 | FORM 4 | 2026-09-24 |
| 2026-09-24 | 144 | 144 | |
| 2026-08-28 | 4/A | FORM 4/A | 2026-08-26 |
| 2026-08-28 | 4/A | FORM 4/A | 2026-08-25 |
| 2026-08-27 | 4 | FORM 4 | 2026-08-26 |
| 2026-08-27 | 4 | FORM 4 | 2026-08-26 |
| 2026-08-27 | 4 | FORM 4 | 2026-08-25 |
| 2026-08-26 | 144 | 144 | |
| 2026-08-26 | 144 | 144 | |
| 2026-08-25 | 144 | 144 | |
| 2026-08-12 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-12 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-12 | 8-K | FORM 8-K items 2.02,9.01 | 2026-08-12 |
| 2026-08-12 | 10-Q | FORM 10-Q | 2026-06-30 |
| 2026-07-22 | S-8 POS | FORM S-8 POS | |
| 2026-07-22 | S-8 POS | FORM S-8 POS | |
| 2026-07-22 | S-8 POS | FORM S-8 POS | |
| 2026-07-22 | S-8 POS | FORM S-8 POS | |
| 2026-07-22 | S-8 | FORM S-8 | |
| 2026-07-22 | 8-K | FORM 8-K items 7.01,9.01 | 2026-07-22 |
Forms on file (last 1,000): 4 221, 8-K 118, 10-Q 26, 3 19, CORRESP 14, SCHEDULE 13G/A 12, 144 11, UPLOAD 11. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=MNPR (0.002 USD), /gw/filings/filings?ticker=MNPR&form=8-K, /gw/filings/facts?ticker=MNPR&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange